SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study
Maria Pia Sormani(University of Genoa), Laura Brambilla(Anna Needs Neuroblastoma Answers), Lucia Moiola(Vita-Salute San Raffaele University), A. Bellacosa, Roberto Bergamaschi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Damiano Baroncini, Marta Radaelli(Humboldt-Universität zu Berlin), Francesca Bovis(Istituto Giannina Gaslini), Roberto Balgera, R. Allegri, Caterina Barrilà, Yára Dadalti Fragoso(Multiple Sclerosis Research Institute), Carlo Antozzi(Fondazione IRCCS Istituto Neurologico Carlo Besta), Alvino Bisecco(University of Campania "Luigi Vanvitelli"), María Trojano(University of Bari Aldo Moro), Paolo Immovilli(University of Florence), Umberto Aguglia(Martin University), Irene Schiavetti(Ospedale Policlinico San Martino), Valeria Bergamaschi, Lucia Appendino, Viola Baione(University of Siena), Doriana Landi(Amsterdam UMC Location Vrije Universiteit Amsterdam), Antonio Bosco, Gıancarlo Comı(Casa di Cura Columbus), Daiana Bezzini(University of Siena), Maria Pia Amato(University of Florence), Valeria Barcella, Lia Allegorico(University of Campania "Luigi Vanvitelli"), Aksel Sıva(Koç University), Marco Salvetti(Istituto Neurologico Mediterraneo), Roberto Furlan(Vita-Salute San Raffaele University), Simona Bonavita, Beatrice Biolzi, Gianmarco Bellucci, Sedat Şen(Ondokuz Mayıs University), Sebastiano Arena, Francesco Patti(University of Catania), Marco Capobianco(Ospedale San Luigi Gonzaga), Mario Alberto Battaglia(University of Siena), Marco Bozzali(CTO Hospital), Gioacchino Tedeschi(University of Campania "Luigi Vanvitelli"), Giovanna Borriello, Cinzia Cordioli(Ospedale Policlinico San Martino), Luca Carmisciano(University of Genoa), Vincenzo Brescia Morra(Federico II University Hospital), Chiara Bosa, Mario Alberto Battaglia(University of Siena), Pietro Annovazzi(Vita-Salute San Raffaele University), Nicola De Rossi, Gianmarco Abbadessa(University of Campania "Luigi Vanvitelli")
Cited by 52
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Multiple Sclerosis Severity Score
|Neurology|2005|959